Stuart T. Haines, Pharm.D., FCCP, FASHP, FAPhA, is Professor in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy in Baltimore, Maryland. Dr. Haines also serves as Clinical Pharmacy Specialist in the Diabetes Management Clinic at the West Palm Beach VA Medical Center in West Palm Beach, Florida. He is a Past-President of the American College of Clinical Pharmacy (ACCP), having served on the ACCP Board of Regents from 2002-2008. He is currently a member of the American Society of Health-System Pharmacists (ASHP) Commission on Credentialing (COC) – the body that sets standards and accredits pharmacy residency and technician training programs in the United States. He has served on numerous editorial boards including Pharmacotherapy, The Annals of Pharmacotherapy, Current Medical Research and Opinion, American Journal of Health-System Pharmacy (AJHP), the Journal of the American Pharmacists Association (JAPhA), as well as the Pharmacist's Letter.

Dr. Haines earned his Bachelor of Science in pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Doctor of Pharmacy degree from the University of Texas at Austin. He completed a pharmacy practice residency at the Brigham and Women's Hospital in Boston, as well as an ambulatory care residency at the University of Texas Health Science Center in San Antonio. He is a board-certified pharmacotherapy specialist (BCPS), and he is also board-certified in advanced diabetes management (BC-ADM). Dr. Haines is a fellow in the American College of Clinical Pharmacy (FCCP), the American Society of Health-System Pharmacists (FASHP), and the American Pharmacists Association (FAPhA). In 2006, Dr. Haines was elected a Distinguished Practitioner in the National Academies of Practice.

Dr. Haines' scholarly interests include medication use behavior, diabetes management, women's health, cardiovascular disease prevention, and the evaluation of instructional methods.

William E. Dager, Pharm.D., FCSHP, FCCP, FCCM, is a board-certified pharmacotherapy specialist who currently holds three academic positions. He is Clinical Professor of Pharmacy at the University of California, San Francisco (UCSF) School of Pharmacy and Clinical Professor of Medicine at the University of California, Davis (UC Davis) School of Medicine. He also serves as Clinical Professor at the Touro School of Pharmacy in Vallejo, California. As a clinical specialist at UC Davis Medical Center, he is responsible for managing challenging cases in anticoagulation, pharmacokinetics, and critical care. Dr. Dager also is clinically active with the cardiology service and serves as the director of the postgraduate year two (PGY2) residency in cardiology at UC Davis.

Dr. Dager earned his Doctor of Pharmacy degree at UCSF and completed a residency at the UC Davis Medical Center in Sacramento. In addition, he completed the University of Pittsburgh Nephrology Pharmaceutical Care Preceptorship. He is a fellow of the California Society of Hospital Pharmacists, American College of Clinical Pharmacy (ACCP), and Society of Critical Care Medicine (SCCM).

Dr. Dager's research interests focus on anticoagulation, critical care medicine, cardiovascular disease, and pharmacokinetics and pharmacodynamics. He has authored numerous articles, book chapters, and scientific reviews, and he has made numerous presentations at national and international educational conferences. He serves as a reviewer and editorial board member for several medical journals, and he currently is chair of the Editorial Advisory Board Panel on Anticoagulation for The Annals of Pharmacotherapy. Dr. Dager also is a site coordinator for the American Society of Health-System Pharmacists (ASHP) Research and Education Foundation Antithrombotic Pharmacotherapy Traineeship.

Dr. Dager has received multiple teaching and professional awards, including the 2008 ACCP Best Practice Award. He is a member of numerous professional organizations, including ACCP, ASHP, Sacramento Valley Society of Health-System Pharmacists, Anticoagulation Forum, International Society of Thrombosis and Haemostasis, and SCCM. He also currently serves as an instructor and regional affiliate faculty member in advanced cardiac life support for the American Heart Association.

Toby C. Trujillo, Pharm.D., BCPS, is Associate Professor of Clinical Pharmacy at the University of Colorado Denver School of Pharmacy in Aurora, Colorado. He also serves as a Clinical Specialist in cardiovascular pharmacotherapy and anticoagulation at the University of Colorado Hospital.

Dr. Trujillo earned his Bachelor of Science degree in biochemistry from the University of California, Davis and his Doctor of Pharmacy degree from the University of California, San Francisco, where he also completed a residency in pharmacy practice. Dr. Trujillo completed a fellowship in cardiovascular pharmacotherapy at The University of Arizona, and he is a board certified pharmacotherapy specialist with added qualifications in cardiology.

Dr. Trujillo's current responsibilities at the University of Colorado Hospital include providing clinical pharmacy services to cardiology, as well as directing the inpatient anticoagulation – thrombosis management service. He also serves as co-chair of the anticoagulation subcommittee of the pharmacy and therapeutics committee. Dr. Trujillo currently serves as a preceptor to both pharmacy students and residents. He provides lectures at the School of Pharmacy on ischemic heart disease, antithrombotic therapy, and other cardiology and critical care topics.

Dr. Trujillo was recently appointed to the Clinical Pharmacology Committee, which resides under the Council on Clinical Cardiology within the American Heart Association. Dr. Trujillo has also served on a number of committees within the American College of Clinical Pharmacy, served as a speaker on numerous occasions on a national level, and authored several papers/book chapters in the area of cardiovascular pharmacotherapy. In addition to being a member of ASHP, Dr. Trujillo helped develop current standards for PGY2 cardiology residency training programs.